重大事件
即時報告
8-K
2026-07-14
Cingulate 股東年會批准股權激勵計劃擴增及董事會重組
AI 繁中摘要
Cingulate Inc. 提交 8-K 報告,匯報 2026 年股東年會結果及董事會變動 📋
**申報類型:8-K(即時報告)**
**報告日期:2026 年 7 月 14 日**(事件發生於 2026 年 7 月 9 日股東年會)
**重點事件:**
1. **股權激勵計劃修正案獲批** ✅
股東在年會上批准《2021 年綜合股權激勵計劃》第三號修正案,授權發行股份增加 **625,000 股**,令總授權股數增至 **2,221,126 股**。投票結果:贊成 3,196,215 票,反對 372,123 票,棄權 35,589 票,券商非投票 4,672,130 票。
2. **董事會結構重組** 🏛️
- 董事會人數由原規模縮減至 **5 人**。
- 行政總裁 **Shane Schaffer** 獲任命為董事會主席。
- **Jeff Hargroves** 獲任命為首席獨立董事,並出任提名及企業管治委員會主席。
- 審計委員會主席由 **Zhanpeng "Frederick" Jiang** 擔任(委員會成員包括 Jiang、Hargroves 及 Bryan Lawrence)。
- 薪酬委員會主席由 **Bryan Lawrence** 擔任(委員會成員包括 Lawrence、Hargroves 及 Jiang)。
3. **其他股東投票結果** 📊
- **選舉董事**:Jeff Hargroves 以 3,563,369 票贊成、40,558 票反對當選第二類董事,任期至 2029 年年會。
- **批准聘任核數師**:股東批准委任 KPMG LLP 為 2026 年度獨立註冊會計師事務所,投票結果:贊成 8,153,858 票,反對 100,881 票,棄權 21,318 票。
- **休會提案**:因已有足夠票數通過各項提案,無需休會,投票結果:贊成 7,563,297 票,反對 663,663 票,棄權 49,097 票。
**對投資者的潛在影響** 💡
- 股權激勵計劃擴大可給予管理層及員工更多股份獎勵,有助留住人才,但同時會攤薄現有股東權益(每股盈利可能受影響)。
- 董事會精簡並明確主席及委員會職責,有助提升決策效率及企業管治水平,正面訊號。
- 公司屬新興成長公司(Emerging Growth Company),仍可選擇延長採用新會計準則的過渡期,投資者宜留意財務報表一致性。
**備註**:修正案詳情已隨 8-K 提交作為附件 10.1。
展開英文正文
false 0001862150 0001862150 2026-07-09 2026-07-09 0001862150 CING:CommonStockParValue0.0001PerShareMember 2026-07-09 2026-07-09 0001862150 CING:WarrantsExercisableForCommonStockMember 2026-07-09 2026-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2026 CINGULATE INC. (Exact name of registrant as specified in its charter) Delaware 001-40874 86-3825535 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1901 W. 47th Place Kansas City, KS 66205 (Address of principal executive offices) (Zip Code) (913) 942-2300 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common Stock, par value $0.0001 per share CING The Nasdaq Stock Market LLC (Nasdaq Capital Market) Warrants, exercisable for common stock CINGW The Nasdaq Stock Market LLC (Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Equity Plan Amendment At the Cingulate Inc. (the “Company”) 2026 Annual Meeting of Stockholders held on July 9, 2026 (the “Annual Meeting”), the Company’s stockholders approved Amendment No. 3 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the “Equity Plan”) to increase the number of shares of common stock authorized for issuance thereunder by 625,000 shares (the “Amendment”). The board of directors of the Company had previously approved the Amendment, subject to stockholder approval, and the Amendment became effective upon such stockholder approval. A copy of the Amendment is included with this Form 8-K as Exhibit 10.1 and is incorporated herein by reference, and the foregoing summary is qualified in its entirety by reference to the terms and provisions of the Amendment. Changes to Board Structure On the date of the Annual Meeting, the Company’s Board of Directors (the “Board”) reduced the size of the Board to five (5) directors and appointed Shane Schaffer, the Company’s Chief Executive Officer, as the chairman of the Board. The Board appointed Jeff Hargroves as the lead independent director of the Board. The Board also appointed Zhanpeng “Frederick” Jiang as the chairman of the Audit Committee of the Board and Mr. Hargroves as the chairman of the Nominating and Corporate Governance Committee of the Board. Following the Annual Meeting: (i) the Audit Committee of the Board consists of Mr. Jiang , as chairman, Mr. Hargroves and Bryan Lawrence, (ii) the Nominating and Corporate Governance Committee of the Board consists of Mr. Hargroves, as chairman, Mr. Jiang and Mr. Lawrence and (iii) the Compensation Committee of the Board consists of Mr. Lawrence, as chairman, Mr. Hargroves and Mr. Jiang. Item 5.07. Submission of Matters to a Vote of Security Holders. At the Annual Meeting, four proposals were submitted to the Company’s stockholders. The final voting results were as follows: Proposal 1 The Company’s stockholders elected the following Class II director to serve for a term expiring at the 2029 annual meeting of stockholders and until his successor has been duly elected. Name For Withhold Broker Non-Votes Jeff Hargroves 3,563,369 40,558 4,672,130 Proposal 2 The Company’s stockholders approved the ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. For Against Abstain Broker Non-Votes 8,153,858 100,881 21,318 0 Proposal 3 The Company’s stockholders approved the Amendment to the Equity Plan to increase the number of shares of common stock authorized for issuance thereunder by 625,000 shares to 2,221,126 shares. For Against Abstain Broker Non-Votes 3,196,215 372,123 35,589 4,672,130 Proposal 4 The Company’s stockholders approved the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of one or more of foregoing proposals. Adjournment of the Annual Meeting was deemed not necessary, because there were sufficient votes at the time of the Annual Meeting to approve each proposal. For Against Abstain Broker Non-Votes 7,563,297 663,663 49,097 0 Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Amendment No. 3 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CINGULATE INC. Dated: July 14, 2026 By: /s/ Shane J. Schaffer Name: Shane J. Schaffer Title: Chief Executive Officer